The pharmaceutical side of the cannabinoid industry continues to grow, with several major announcements expanding treatments and blurring boundaries
Written by Lorraine Mullaney || 3rd September 2020 || News analysis | Companies | Health and science | Regulation and legislation | US federal regulation | Canada North America United States